| |
| |
|
| Insider
Information: |
Eshelman Fredric N |
| Relationship: |
10% Owner |
| City: |
Wilmington |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
8,151,654 |
|
|
Indirect Shares
|
3,933,809 |
|
|
| Direct
Value |
$83,566,297 |
|
|
|
Indirect Value
|
$18,625,640 |
|
|
| Total
Shares |
12,085,463 |
|
|
| Total
Value |
$102,191,938 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
7
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -45.7%
|
-43.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
4,982,263 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
8,450,636 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2009-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
11,258 |
11,258 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2009-08-28 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
6,997,871 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
38,000 |
7,035,871 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2011-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
7,050,871 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2011-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
6,984,741 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • • |
2013-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,161 |
2,673,522 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,096 |
1,096 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
16,726 |
17,822 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,406 |
38,298 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • • |
2017-05-22 |
4 |
A |
$0.00 |
$0 |
I/I |
3,139,151 |
3,139,151 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • • |
2018-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
1,277,461 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,038 |
1,285,499 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
1,292,787 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2011-05-18 |
4 |
B |
$14.52 |
$182,937 |
D/D |
12,599 |
604,088 |
2.39 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2011-05-19 |
4 |
B |
$14.12 |
$177,898 |
D/D |
12,599 |
616,687 |
2.39 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2011-05-20 |
4 |
B |
$13.99 |
$6,505,350 |
D/D |
465,000 |
1,081,687 |
2.39 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2011-05-24 |
4 |
B |
$14.79 |
$214,692 |
D/D |
14,516 |
1,096,203 |
2.39 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2011-05-25 |
4 |
B |
$15.35 |
$3,837,500 |
D/D |
250,000 |
1,346,203 |
2.39 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-04 |
4 |
B |
$14.92 |
$106,052 |
D/D |
6,922 |
1,353,125 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-07 |
4 |
B |
$15.69 |
$112,152 |
D/D |
7,148 |
1,360,273 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-08 |
4 |
B |
$16.00 |
$4,000,000 |
D/D |
250,000 |
1,610,273 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-09 |
4 |
B |
$16.26 |
$15,398 |
D/D |
947 |
1,611,220 |
3.92 |
- |
|
148 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
